CHRNA9 Antikörper (N-Term)
Kurzübersicht für CHRNA9 Antikörper (N-Term) (ABIN926964)
Target
Alle CHRNA9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Hund, Maus, Ratte (Rattus), Huhn
-
Aufreinigung
- Purified
-
Immunogen
- CHRNA9 antibody was raised in rabbit using the N terminal of CHRNA9 as the immunogen
-
-
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 8-42), (N-Term) antibody
CHRNA9 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB46802 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 26-240) antibodyCHRNA9 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 139-221) antibodyCHRNA9 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 8E4 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 8-42) antibodyCHRNA9 Reaktivität: Human WB, IHC, FACS, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio), Schwein, Fledermaus, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Maus, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) antibodyCHRNA9 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Pferd, Kaninchen, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
WB: 0.0625 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CHRNA9 Blocking Peptide, (ABIN5612869), is also available for use as a blocking control in assays to test for specificity of this CHRNA9 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
-
Andere Bezeichnung
- CHRNA9
-
Hintergrund
- CHRNA9 is a member of the ligand-gated ionic channel family and nicotinic acetylcholine receptor superfamily. CHRNA9 is a plasma membrane protein that forms homo- or hetero-oligomeric divalent cation channels. It is involved in cochlea hair cell development and is also expressed in the outer hair cells (OHCs) of the adult cochlea. Synonyms: Polyclonal CHRNA9 antibody, Anti-CHRNA9 antibody, cholinergic receptor, nicotinic, alpha 9 antibody.
-
Pathways
- Sensory Perception of Sound
Target
-
